CRESPIATICO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 880
EU - Europa 810
AS - Asia 135
OC - Oceania 4
AF - Africa 1
SA - Sud America 1
Totale 1.831
Nazione #
US - Stati Uniti d'America 869
IT - Italia 351
DE - Germania 140
IE - Irlanda 105
CN - Cina 46
SE - Svezia 44
FR - Francia 41
GB - Regno Unito 38
RU - Federazione Russa 34
HK - Hong Kong 32
SG - Singapore 26
FI - Finlandia 14
IN - India 11
CA - Canada 9
BE - Belgio 7
CZ - Repubblica Ceca 7
ID - Indonesia 7
ES - Italia 6
VN - Vietnam 6
PL - Polonia 5
AU - Australia 4
DK - Danimarca 4
NL - Olanda 3
NO - Norvegia 3
RO - Romania 3
TR - Turchia 3
JP - Giappone 2
MX - Messico 2
UA - Ucraina 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
MU - Mauritius 1
Totale 1.831
Città #
Ann Arbor 350
Milan 109
Dublin 105
Frankfurt am Main 104
Fairfield 68
Wilmington 59
Chandler 54
Ashburn 46
New York 42
Hong Kong 32
Houston 32
Seattle 32
Woodbridge 25
Paris 21
Cambridge 19
Shanghai 19
Monza 18
Princeton 12
Singapore 11
Slough 11
Helsinki 10
Altamura 9
Carate Brianza 9
Desio 9
Essen 9
Florence 9
Los Angeles 9
Rome 8
Jakarta 7
Beijing 6
Brno 6
Lawrence 6
Lodi 6
Munich 6
Turin 6
Cinisello Balsamo 5
Dong Ket 5
Genoa 5
Grafing 5
Guangzhou 5
Meda 5
Stockholm 5
Washington 5
Boardman 4
Brampton 4
Cagliari 4
Dearborn 4
Duncan 4
Fremont 4
Lappeenranta 4
Leuven 4
Lodz 4
London 4
Perth 4
Sesto San Giovanni 4
Arese 3
Bonndorf 3
Brussels 3
Ceret 3
Cesena 3
Corbetta 3
Fontaniva 3
Kilburn 3
Kocaeli 3
Lleida 3
Nanjing 3
Naples 3
Parma 3
Rho 3
San Francisco 3
Shenyang 3
Usmate Velate 3
Agrate Brianza 2
Aragona 2
Atlanta 2
Barcelona 2
Bhopal 2
Bradford 2
Cassolnovo 2
Cesano Maderno 2
Chicago 2
Como 2
Cruseilles 2
Cuauhtémoc 2
Dortmund 2
Hebei 2
Hyderabad 2
Iasi 2
Jacksonville 2
Lissone 2
Milton Keynes 2
Monmouth Junction 2
Muggiò 2
Nanchang 2
Nichelino 2
Nova Milanese 2
Novara 2
Oslo 2
Ottawa 2
Pandino 2
Totale 1.479
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 374
An Imatinib–non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization 252
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 235
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 230
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 217
Long-term Results after Hyaluronan-based MACT for the Treatment of Cartilage Lesions of the Patellofemoral Joint 115
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 114
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 79
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 68
Idiopathic erythrocytosis: a germline disease? 47
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 47
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 44
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 42
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 40
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 32
Totale 1.936
Categoria #
all - tutte 6.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020208 0 9 8 7 10 41 34 19 23 36 14 7
2020/2021439 12 4 22 27 23 25 112 60 39 35 45 35
2021/2022209 32 31 29 17 22 17 4 10 9 10 14 14
2022/2023320 24 71 34 16 32 36 22 13 23 8 17 24
2023/2024655 100 25 27 41 44 109 101 32 50 49 23 54
2024/202576 63 13 0 0 0 0 0 0 0 0 0 0
Totale 1.936